Here’s a rapid-fire update on all 34 stocks in Jim Cramer’s Charitable Trust, the holdings we manage in the CNBC Investing Club.
Tag: Johnson & Johnson
A flurry of earnings reports, Fed rate hike, signs of a bull market
Earnings season continues next week, with Club holdings Linde (LIN), Emerson Electric (EMR) and Walt Disney (DIS) all set to report. We’ll
FDA clearance of Covid shots and treatments won’t slow with end of public health emergency
Vials and a medical syringe seen displayed in front of the Food and Drug Administration (FDA) of the United States logo. FDA
We're buying up more shares of this pharmaceuticals play on weakness
The Club is adding to our position in a key holding as its share price drops. Sumber: www.cnbc.com
Prepare for a deluge of data next week that will shape the Fed’s next move
Buckle up, next week is a big one: We’ll see lots of quarterly reports as this earnings season ramps into high gear,
Earnings could keep the market on edge in week ahead as investors wait for Fed
Earnings news will keep investors busy and markets volatile in the coming week, as the Federal Reserve’s next rate hike gets closer.
These 6 Club stocks look reasonably priced as Wall Street shuns high flyers
We’re growing increasingly worried about some richly valued companies in our portfolio, including the likes of Nvidia (NVDA) and Microsoft (MSFT). Expensive
Three painful lessons for investors in 2022. How to put them to work in the new year
Perhaps the one thing that investors can rally around is this: 2022 is finally over. There was nowhere to hide last year.
Top analysts say buy stocks like Papa John’s and Alphabet
We step into the new year with a largely unchanged macroeconomic backdrop and a recession waiting for us. However, investors can maintain a healthy
Cramer’s final thoughts for the year: Making sense of multiples
The price-to-earnings multiples say recession. But the multiples said similar things in 2022. So how long can the multiples stay this low?
No More Posts Available.
No more pages to load.